These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22646842)

  • 1. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.
    Ritchie SA; Patel MJ; Miller SJ
    Dermatol Surg; 2012 Oct; 38(10):1604-21. PubMed ID: 22646842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy.
    Willey A; Mehta S; Lee PK
    Dermatol Surg; 2010 May; 36(5):652-8. PubMed ID: 19889154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment.
    Kim C; Cheng J; Colegio OR
    Semin Oncol; 2016 Jun; 43(3):390-4. PubMed ID: 27178693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capecitabine for skin cancer prevention in solid organ transplant recipients.
    Jirakulaporn T; Endrizzi B; Lindgren B; Mathew J; Lee PK; Dudek AZ
    Clin Transplant; 2011; 25(4):541-8. PubMed ID: 21050273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
    Schauder DM; Kim J; Nijhawan RI
    JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocyte cancer and its precursors in organ transplant patients.
    Jenni D; Hofbauer GF
    Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.
    Endrizzi B; Ahmed RL; Ray T; Dudek A; Lee P
    Dermatol Surg; 2013 Apr; 39(4):634-45. PubMed ID: 23379978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
    Herold M; Good AJ; Nielson CB; Longo MI
    Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
    Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
    Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Organ transplant recipients need intensive control and treatment of skin cancer].
    Togsverd-Bo K; Sørensen SS; Hædersdal M
    Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients.
    Jambusaria-Pahlajani A; Ortman S; Schmults CD; Liang C
    Dermatol Surg; 2016 Jan; 42 Suppl 1():S66-72. PubMed ID: 26730976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview on non-melanoma skin cancers in solid organ transplant recipients.
    Forchetti G; Suppa M; Del Marmol V
    G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
    Tessari G; Girolomoni G
    Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment of field cancerization.
    Ulrich C
    Cancer Treat Res; 2009; 146():439-46. PubMed ID: 19415223
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
    Cheng JY; Li FY; Ko CJ; Colegio OR
    JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
    Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
    JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
    Herman S; Rogers HD; Ratner D
    Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatopathology of skin cancer in solid organ transplant recipients.
    Stoff B; Salisbury C; Parker D; O'Reilly Zwald F
    Transplant Rev (Orlando); 2010 Oct; 24(4):172-89. PubMed ID: 20709518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and posttransplant management of solid organ transplant recipients: risk-adjusted follow-up.
    Shafaeddin Schreve B; Anliker M; Arnold AW; Kempf W; Laffitte E; Lapointe AK; Mainetti C; Pelloni F; Oberholzer P; Serra A; Streit M; Hofbauer GF;
    Curr Probl Dermatol; 2012; 43():57-70. PubMed ID: 22377920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.